Skip to main content
SpringerLink
Log in
Book cover

ECTO-NOX Proteins pp 419–434Cite as

Cancer Diagnostic Applications of ENOX2 Proteins

  • Chapter
  • First Online:

  • 652 Accesses

Abstract

That the cancer cell surface-located ENOX2 proteins are produced only by cancer cells and shed into the blood offer an opportunity for cancer detection based on serum analyses including early stages when the cancer is localized and potentially curable. Transcription variants of ENOX2 are well suited as absolute cancer-specific molecular targets for early diagnosis of cancer and recurrent disease. Each major form of human cancer presents with at least one, at most two, characteristic transcript variants of molecular weight and isoelectric point that are specific for the organ of cancer origin. Variants are revealed by two-dimensional gel electrophoresis with detection using a recombinant single chain variable region (scFv antibody specific for ENOX2 transcript variants. As the transcript variants are molecular signature molecules produced only by cancer cells, absent from noncancer cells, and not produced by benign or inflammatory conditions, false positive, in principle, are eliminated. The strategy of early detection combined with early intervention opportunities described in Chap. 11 raises the possibility of a significant paradigm shift in cancer management toward early diagnosis and treatment options vastly different from those currently employed to deal primarily with advanced cancer.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariott A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK (eds) (2010) SEER cancer statistics review, 1975–2007. National Cancer Institute, Bethesda, MD

    Google Scholar 

  • Bertucci F, Goncalves A (2008) Clinical proteomics and breast cancer: strategies for diagnostic and therapeutic biomarker discovery. Future Oncol 4:271–287

    Article  PubMed  CAS  Google Scholar 

  • Cho NM, Chueh P-J, Kim C, Caldwell S, Morré DM, Morré DJ (2002) Monoclonal antibody to a cancer-specific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients. Cancer Immunol Immunother 51:121–129

    Article  PubMed  CAS  Google Scholar 

  • Chueh P-J, Kim C, Cho N, Morré DM, Morré DJ (2002b) Molecular cloning and characterization of a tumor-associated, growth-related and time-keeping hydroquinone (NADH) oxidase (NOX) of the HeLa cell surface. Biochemistry 41:3732–3741

    Article  PubMed  CAS  Google Scholar 

  • De Luca T, Morré DM, Morré DJ (2010) Reciprocal relationship between cytosolic NADH and ENOX2 inhibition triggers sphingolipid-induced apoptosis in HeLa cells. J Cell Biochem 110:1504–1511

    Article  PubMed  Google Scholar 

  • Dnistrian AM, Schwartz MK, Katopodis N, Fracchia AA, Stock CC (1982) Serum lipid-bound sialic acid as a marker in breast cancer. Cancer 50:1815–1819

    Article  PubMed  CAS  Google Scholar 

  • Hostetler B, Kim C (2011) Detecting neoplasia-specific tNOX isoforms. Patent GB2441860

    Google Scholar 

  • Hostetler B, Weston N, Kim C, Morré DM, Morré DJ (2009) Cancer site-specific isoforms of ENOX2 (tNOX), a cancer-specific cell surface oxidase. Clin Proteomics 5:46–51

    Article  CAS  Google Scholar 

  • Kim C (2011) Single chain pan ECTO-NOX variable region (ScFv) antibody, coding sequence and methods. Patent GB2442553B

    Google Scholar 

  • Lengle EE (1979) Increased levels of lipid-bound sialic acid in thymic lymphocytes and plasma from leukemic AKR/J mice. J Natl Cancer Inst 62:1564–1579

    Google Scholar 

  • Morré DJ (1995a) NADH oxidase activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-4-methylphenylsulfonyl-N′-4-chlorophenylurea LY181984 at an external site. Biochim Biophys Acta 1240:201–208

    Article  PubMed  Google Scholar 

  • Morré DJ (1998c) NADH oxidase: a multifunctional ectoprotein of the eukaryotic cell surface. In: Asard H, Bérczi A, Caubergs R (eds) Plasma membrane redox systems and their role in biological stress and disease. Kluwer Academic, Dordrecht, The Netherlands, pp 121–156

    Google Scholar 

  • Morré DJ, Morré DM (2003a) Cell surface NADH oxidases (ECTO-NOX proteins) with roles in cancer, cellular time-keeping, growth, aging and neurodegenerative disease. Free Radic Res 37:795–808

    Article  PubMed  Google Scholar 

  • Morré DJ, Reust T (1997) A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea N-4-methylphenylsulfonyl-N′-4-chlorophenylurea LY181984 specific to sera from cancer patients. J Bioenerg Biomembr 29:281–289

    Article  PubMed  Google Scholar 

  • Morré DJ, Chueh P-J, Morré DM (1995b) Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc Natl Acad Sci U S A 92:1831–1835

    Article  PubMed  Google Scholar 

  • Morré DJ, Wu L-Y, Morré DM (1995i) The antitumor sulfonylurea N-4-methylphenylsulfonylurea-N′-chlorophenylurea LY181984 inhibits NADH oxidase activity of HeLa plasma membranes. Biochim Biophys Acta 1240:11–17

    Article  PubMed  Google Scholar 

  • Morré DJ, Wilkinson FE, Kim C, Cho N, Lawrence J, Morré DM, McClure D (1996c) Antitumor sulfonylurea-inhibited NADH oxidase of cultured HeLa cells shed into media. Biochim Biophys Acta 1280:197–206

    Article  PubMed  Google Scholar 

  • Morré DJ, Caldwell S, Mayorga A, Wu L-Y, Morré DM (1997a) NADH oxidase activity from sera altered by capsaicin is widely distributed among cancer patients. Arch Biochem Biophys 342:224–230

    Article  PubMed  Google Scholar 

  • Morré DJ, Kim C, Paulik M, Morré DM, Faulk WP (1997c) Is the drug-responsive NADH oxidase of the cancer cell plasma membrane a molecular target for adriamycin? J Bioenerg Biomembr 29:269–280

    Article  PubMed  Google Scholar 

  • Morré DJ, Bridge A, Wu L-Y, Morré DM (2000a) Preferential inhibition by (−)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture. Biochem Pharmacol 60:937–946

    Article  PubMed  Google Scholar 

  • Morré DJ, Pennington KL, Hignite H, Orvis H, Schwartzentruber DJ, Tang X, Morré DM (2005) Detection of blood-borne cancer using polymerase chain reaction for tNOX messenger RNA. In: Abstracts, 97th annual meeting, American Association for Cancer Research, Washington, DC, 1–5 April 2006. Abstract No. 5684, pp 1336–1337

    Google Scholar 

  • Morré DJ, Tang X, Morré DM, Pennington KL, Hignite H, Orvis H, Schwartzentruber DJ (2006b) RTPCR detection of cancer cells in blood based in presence of a tNOX splice variant mRNA. In: Abstracts, Fourth Early Detection Research Network (EDRN) scientific workshop, 20–22 March 2006, Philadelphia, PA, p 60

    Google Scholar 

  • Morré DJ, Hostetler B, Weston N, Kim C, Morré DM (2009a) Cancer type-specific tNOX isoforms: a putative family of redox protein splice variants with cancer diagnostic and prognostic potential. Biofactors 34:201–207

    Article  Google Scholar 

  • Morré DJ, McClain N, Wu L-Y, Kelly G, Morré DM (2009b) Phenoxodiol treatment alters the subsequent response of tNOX and growth of HeLa cells to paclitaxel and cis-platin. Mol Biotechnol 42:100–109

    Article  PubMed  Google Scholar 

  • Navarrete-Montalvo D, Gonzalez MN, Montalyo VMT, Jimenez AA, Echiburu-Chau C, Calaf GM (2008) Patterns of recurrence and survival in breast cancer. Oncol Rep 20:531–535

    PubMed  Google Scholar 

  • Petro R, Darby S, Deo H, Silcocks P, Whitley E, Doll R (2000) Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. Br Med J 321:323–329

    Article  Google Scholar 

  • Portoukalian J, Zwingelstein G, Abdul-Malak N, Dore JF (1978) Alteration of gangliosides in plasma and red cells of humans bearing melanoma tumors. Biochem Biophys Res Commun 85:916–920

    Article  PubMed  CAS  Google Scholar 

  • Rim A, Chellman-Jeffers M (2008) Trends in breast cancer screening and diagnosis. Cleve Clin J Med 75:S2–S9

    Article  PubMed  Google Scholar 

  • Sallay SL, Prosise WN, Morré DJ, Matyas GR (1986) Ganglioside and PCA sialic acid serum levels in cancer. Cancer J 1:124–129

    Google Scholar 

  • Tang X, Tian Z, Chueh P-J, Chen S, Morré DM, Morré DJ (2007) Alternative splicing as the basis for specific localization of tNOX, a unique hydroquinone (NADH) oxidase, to the cancer cell surface. Biochemistry 46:12337–12346

    Article  PubMed  CAS  Google Scholar 

  • Tang X, Morré DJ, Morré DM (2008) Antisense experiments demonstrate an exon 4 minus splice variant mRNA as the basis for expression of tNOX, a cancer-specific cell surface protein. Oncol Res 16:557–567

    Article  Google Scholar 

  • Weinberg RA (2007) The biology of cancer, Fig. 11.1, p. 400. Courtesy of Hong, W. K., compiled from SEER Cancer Statistics Review, Garland Science, Oxford

  • Wilkinson FE, Kim C, Cho N, Chueh P-J, Leslie S, Moya-Camarena S, Wu L-Y, Morré DM, Morré DJ (1996) Isolation and identification of a protein with capsaicin-inhibited NADH oxidase activity from culture media conditioned by growth of HeLa cells. Arch Biochem Biophys 336:275–282

    Article  PubMed  CAS  Google Scholar 

  • Yadav BS, Sharma SC, Singh R, Singh G (2007) Patterns of relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy followed by surgery and radiotherapy. J Cancer Res Ther 3:75–80

    Article  PubMed  CAS  Google Scholar 

  • Yantiri F, Morré DJ (2001) Isolation and characterization of a tumor-associated NADH oxidase (tNOX) from the HeLa cell surface. Arch Biochem Biophys 391:149–159

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mor-NuCo, LLC, Purdue Research Park, West Lafayette, IN, USA

    D. James Morré & Dorothy M. Morré

Authors
  1. D. James Morré
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dorothy M. Morré
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this chapter

Cite this chapter

Morré, D.J., Morré, D.M. (2012). Cancer Diagnostic Applications of ENOX2 Proteins. In: ECTO-NOX Proteins. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3958-5_12

Download citation

Publish with us

Policies and ethics

Search

Navigation